Enfermedades Infecciosas y Microbiología Clínica

Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa Lorena López-Cerero; Sofia Ballesta; Cristina Elías López; Waldo Sánchez-Yebra; María Dolores Rojo-Martin; Alvaro Pascual;

Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis Inês Leonor Leitão; Carla Mimoso Santos; Paulo André; Sara Lino; Marcos Lemos; Filipe Froes;

Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria Vicente Pintado; Patricia Ruiz-Garbajosa; David Aguilera-Alonso; Fernando Baquero-Artigao; Germán Bou; Rafael Cantón; Santiago Grau; Belén Gutiérrez-Gutiérrez; Nieves Larrosa; Isabel Machuca; Luis Martínez Martínez; María Milagro Montero; Elena Morte-Romea; Antonio Oliver; José Ramón Paño-Pardo; Luisa Sorlí;